This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant in the amount of $274,811 awarded to Anova Biomedical, Inc. in Ithaca, NY aims to develop a novel 3D printing resin for the production of personalized, elastic, and bioresorbable vascular grafts. The key objectives of this 1-year award are to: 1) develop, characterize, and optimize the 3D printing resin; 2) demonstrate the ability to 3D print personalized vascular grafts using patient CT...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,822 to Tissueform, Inc., a woman-owned small business located in Boulder, Colorado, aims to develop a library of human-based bioinks for 3D bioprinting applications. The project, spanning September 2024 to August 2025, will focus on creating granulated bioinks for tissues such as cartilage, bone, skin, liver, and kidney to advance drug discovery and organ-on-chip models....
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $550,000 to the President and Fellows of Harvard College aims to develop a minimally-invasive, catheter-based additive manufacturing platform for creating customized medical implants inside the human body. The key research objectives include designing and optimizing soft, implant-grade biomaterials that can be delivered through catheters to form 3D structures in-vivo, as well as...
This $200,000 federal Project Grant awarded by the National Science Foundation (NSF) under the Engineering (CFDA 47.041) program supports research to develop advanced 4D bioprinting technologies. The goal is to create soft robotic systems capable of targeted stem cell delivery within a biomimetic environment. Specifically, the project aims to synthesize a multi-responsive and magnetically controllable 4D ink material for bioprinting structures, and to fabricate soft robots that can load, dock,...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant of $274,999 awarded to Materialize Bio, Inc. focuses on developing a novel manufacturing approach for biopolymer-based implantable medical devices, specifically bioengineered tympanostomy tubes. The project aims to create degradable, biocompatible, and antimicrobial tympanostomy tubes using an innovative process involving 3D printed molds, centrifugation, and polymerization. This...
The National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded a $135,000 Project Grant to the University of Central Florida (UCF) for the project "COLLABORATIVE RESEARCH: EAGER: 3D BIOPRINTED ORGANOIDS FOR STUDYING THE MECHANISM OF CEREBROVASCULAR AGING". This award supports the development of 3D bioprinted cerebrovascular organoids derived from human induced pluripotent stem cells to study the impact of cellular senescence...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Meteora3D, Incorporated will support the development of a rapid lift-based peel separation system for inverted stereolithography 3D printing. The project aims to increase 3D printing throughput by 6x compared to current desktop methods, enabling the use of 3D printed anatomic models for urgent surgical planning. Key objectives include theoretical analysis of the peel...
The National Science Foundation (NSF) awarded a Project Grant through its Directorate for Technology, Innovation, and Partnerships (CFDA 47.084) to Georgia Tech Research Corporation in the amount of $249,689 for the project "3D Printed Tissue Implants for Facial Surgery." The project aims to develop a platform for 3D printing tissue implants for facial surgery, enabling the design and rapid manufacturing of implants for tissue reconstruction. The work will involve evaluating the impact...
This National Science Foundation Project Grant of $319,476 will fund research at the University of Virginia from March 2023 through February 2026 under the Engineering program (CFDA 47.041). The research aims to establish the foundational science for voxelated bioprinting through elucidating the nonlinear fluid dynamics of all-aqueous printing of viscoelastic droplets in yield-stress fluids. A printing platform will be developed to study droplet printing dynamics in real time. Control strategies...
Biosapien Inc. received a $256,000 Project Grant award from the National Science Foundation on May 1, 2021 to develop a novel 3D printed biodegradable mesh delivering active pharmaceutical ingredients in a sustained and localized manner under the Small Business Innovation Research Phase I program. The SBIR Phase I grant supports the proof-of-concept stage of developing Biosapien's technology, with the work expected to be completed by June 30, 2022. The NSF Technology, Innovation, and...